Stem Cells Fail to Reduce Brain Inflammation in Active MS & Switching MS Carers Temporarily

Jan 17, 12:00 AM

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses treatment with mesenchymal stem cells or MSCs in adults with active MS failed to significantly reduce brain inflammation, trial data show. Plus, reads the column by John Connor, Fall Down, Get Up Again, “There’s a New Primary Carer in Town”.
Are you interested in learning more about multiple sclerosis? If so, please visit:
To join in on conversations regarding multiple sclerosis, please visit: